ReleaseWire Connect

H1N1 influenza (zoonotic) is an infectious disease in humans caused by a variant of the swine H1N1 virus, known as H1N1v virus. The H1N1v virus is a contagious virus which infects nose, throat, and lungs. H1N1 virus is an RNA virus belonging to the Orthomyxoviridae family. Influenza A viruses infect different animal species such as humans, swine, birds, seals, and horses. Influenza A viruses can be subdivided on the basis of antigenicity of its surface glycoproteins neuraminidase and hemagglutinin. Hemagglutinin component is used by the virus to bind to host cell receptors. This facilitates viral entry into the host cell. Neuraminidase protein enzymatically cleaves terminal sialic acid residues from mucins, thereby allowing the virus to reach underlying cells in the respiratory tract. Elderly people, young children, and people with medical conditions including liver disorders, blood disorders, kidney disorders, chronic lung disease, asthma, and neurodevelopmental and neurological conditions are at a higher risk of getting infected. Influenza vaccines are administered for active immunization against influenza virus. This, in turn, confers protection against influenza disease. Vaccination of high-risk groups prevents unnecessary hospitalizations and premature deaths resulting due to influenza.

The global patient engagement solutions market is estimated to grow at a CAGR of 20% from 2014 to 2019, to reach $13.7 billion by 2019 from $5.5 billion in 2014.Over the years, the traditional approaches to patient care, quality assurance, and cost management have been inefficient.Thereforepatient engagement solutions will be among the priorities on the investment list of healthcare organizations for improving quality outcomes and cost management. Based on the mode of delivery, web-based solutions accounted forthe largest segment of the patient engagement solutions market in 2014. However, cloud-based solutions are the fastest-growing delivery modes.

ReportsnReports.com adds "Market Research Report on Global and Chinese Coconut oil Industry, 2009-2019" report to its research store.

RnRMarketResearch.com adds “Market Research Report on Global and Chinese Magenta (CAS 632-99-5) Industry, 2009-2019” new market research report to its store.

The global transcriptomics market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has blatantly grown in the past few years primarily due to the increasing technological advancements in the field of sequencing technologies in transcriptomics research. Similarly, the increasing government and private funding for research coupled with research and development investments by the biotechnology companies are expected to drive the transcriptomics market. The increasing adoption of transcriptomics in the field of biomarker discovery opens new growth avenues with the rising preference of personalized medicine across the globe. However, the higher investment costs that restrict the adoption of transcriptomics products and dearth of skilled professionals are the factors hampering the growth of this market to a certain extent.

ReportsnReports.com adds "Market Research Report on Global and Chinese Wireless Adapter Industry, 2009-2019" report to its research store.

The global fuel cell market size is estimated to reach $5.20 billion, by 2019. The unit shipments of fuel cells are expected to increase from 62,197 units in 2013, to 214,369 by 2019. Major factors responsible for the growth of fuel cell market include the ability of fuel cells in stationary, portable and transportation applications to function as an off grid power source, which has zero emission and is cleaner. The key concerns in the industry pertain to the high cost of catalyst, commercialization of fuel cells, and establishment of fuel cell infrastructure.

Research’s report, “Picture Archiving and Communication Systems Market to 2020 - Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth” discusses the market, competitive landscape, and trends for two Picture Archiving and Communications Systems (PACS) market segments: radiology PACS and cardiology PACS. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the overall market. The report also reviews the competitive landscape, analyzes pipeline products by segment and gives details of important Merger and Acquisition (M&A) deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Research, the leading business intelligence provider, has released its latest research, ‘Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 – New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries’, which provides insights into Major Depressive Disorder (MDD) in the major developed markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment use patterns, in-depth analysis of the pipeline, clinical trial failure rate and deal analysis for MDD. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis carried out by GBI Research’s team of industry experts. In 2013, the value of the MDD therapeutics market in major developed countries amounted to an estimated $8.7 billion. The market is forecast to decline at a negative Compound Annual Growth Rate (CAGR) of 1.1% between 2013 and 2020 to reach $8.1 billion. The decline is due to key patent expiries of blockbuster drugs such as Lexapro, Cymbalta, Abilify, and Seroquel XR during the forecast period. The expected launch of few promising pipeline molecules such as brexpiprazole, cariprazine, ALKS-5461, GLYX-13 is likely to offset the key patent expiries. Recently launched Brintellix which has a novel multimodal mechanism of action and is the only drug which can provide improvements in cognitive function is expected to lead the market by the end of forecasting period.

ReportsnReports.com adds "Market Research Report on Global and Chinese Particleboard (Chipboard) Industry, 2009-2019" report to its research store.